Systemic Anaplastic Lymphoma Kinase-positive Anaplastic Large Cell Lymphoma: A Population-based Analysis of Incidence and Survival.

CONCLUSION: Incidence and survival of ALK-positive ALCL varies significantly with patients' demographic characteristics as identified in our study. Treatment strategies need to be tailored accordingly to address these variations and ensure uniform access to care.
PMID: 28395812 [PubMed - in process]

Source: Clinical Lymphoma and Myeloma - April 1, 2017 Category: Cancer & Oncology Authors: Guru Murthy GS, Hamadani M, Bhatt VR, Dhakal I, Mehta P Tags: Clin Lymphoma Myeloma Leuk Source Type: research